For three days from 27 to 29 August – the capital of Tatarstan will become a center for discussion of the most topical issues of the pharmaceutical market of Russia in the framework of the GMP III all-Russian conference with international participation.
The title and the Central theme of the conference in 2018 “Russia and the world. Management of the growth potential of the pharmaceutical market”. The event will be attended by over a thousand participants and 20 foreign delegations, including representatives of the GMP inspectorates of the BRICS countries, Europe, Japan, Canada, industry associations, CEOs and owners of companies.
The business program promises to be eventful and interesting. Conference participants will discuss the various issues that arise today in the pharmaceutical industry: the development of the Russian pharmaceutical market in the future, its interaction with the international community, measures of state regulation, and many others.
For three days in plenary sessions, panel discussions, meetings and workshops international experts will share their experience and discuss topical issues.
In a panel discussion on the modern regulatory system will be presented the first results of work of Federal law No. 140-FZ. Will be announced the main trends of the modern regulatory systems in the countries of the ICH region. The conference participants will discuss the issues of rational use of resources and inter-country cooperation in the field of GMP, harmonization of approaches to the assessment of GMP in the framework of PIC/S, recent trends and current status of the draft document PIC/S classification of discrepancies.
Different approaches to GMP inspection in different regulatory jurisdictions, the impact of global regulatory approaches on regulatory compliance and drug development, a new emphasis in the regulatory system of the EEU in the context of good manufacturing practice – is not a complete list of all the topics of the conference.
It should be noted that the range of issues this year has become much wider. The latest industry technology, digital transformation, program strategy “Farma-2030”, the certification of the authorized persons according to the requirements of the EEU, IV, the Industrial revolution, the questions of licensing of separate groups of drugs – these and many other topics will be discussed in the framework of the program of the conference. In addition, this year significantly increased the number of foreign experts who are ready to share international experience in the stated order.
The significance of the event for the industry, said the representatives of the companies who supported the conference this year.
The General partner of III all-Russian conference of the GMP is the company JSC “Valenta Pharm”, headed by Anton Strekalov: “We believe that GMP III all-Russian conference is an important platform for exchange of experience between pharmaceutical companies. Confident that the event will boost the production of quality medicines in our country.”
This year the company JSC “Gedeon Richter” will also serve as a strategic partner of the conference: “Along with the efficiency, safety and accessibility a priority for the company “Gedeon Richter” is to ensure the quality of medicines. And we are pleased that for the third year there are area – GMP-conference with international participation “Russia and the world. Management of the growth potential of the pharmaceutical market”, which allows industry experts to discuss and promptly resolve the outstanding issues” – commented Natalia Volovich, Deputy Director, head of Department for registration of representative office of “Gedeon Richter”.
Strategic partner of JSC “tatchempharmpreparaty” expresses gratitude on behalf of the General Director Timur Khannanov and supported the conference: “This event is a unique platform for exchange of views on topical issues of the Russian pharmaceutical market, as well as on the further development of the industry for the production of medicines in strict accordance with international and Russian standards of good manufacturing practice (GMP). Today such discussions are particularly important because of modernization and innovative development of our country has come to the fore”.
Partners of the conference will also address: JSC “Astellas Pharma”, OOO “Takeda pharmaceuticals”. Some sessions will be held with the support of companies JSC “Akrikhin”, JSC Amgen, JSC “Bosnalek”, “ABOUT.MED.Cs Praha a.on.”, JSC “farmimeks”. While a special partner is the company GEROPHARM.
Strategic information partner – the newspaper, TV portal and Pharmaceutical Bulletin.
Thanks to the support of these companies the participation is free for all members of the pharmaceutical community.
The event is organized by the Ministry of industry and trade of the Russian Federation and the Federal budgetary organization “State Institute of drugs and good practices”, the operator of the conference – corporate communications Center “C-GROUP”.
Venue: Business center “Korston”, Ershova St. Nicholas, 1A, Kazan
The event program
To become a participant by filing an application on the official website of the event.
More information is available on the official conference website and accounts in social networks (VK, Facebook)